The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan-Reference-Cited by-同舟云学术

The MIHARI project: establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan

Published:2016-05-25 Issue:7 Volume:25 Page:854-859
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Ishiguro Chieko¹,Takeuchi Yoshinori¹,Uyama Yoshiaki¹,Tawaragi Tomiko¹

Affiliation:

1. Office of Medical Informatics and Epidemiology; Pharmaceuticals and Medical Devices Agency; Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference22 articles.

1. Post-market drug safety evidence sources: an analysis of FDA drug safety communications;Ishiguro;Pharmacoepidemiol Drug Saf,2012

2. FDA's Sentinel Initiative http://www.fda.gov/Safety/FDAsSentinelInitiative/default.htm

3. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) http://www.encepp.eu/

4. Validation of outcome definition of acute renal failure in Japanese electronic medical records data;Yamada;Pharmacoepidemiol Drug Saf,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Utilization of Drug Lifecycle Data in the United States, Japan, and Europe;Journal of Health Informatics and Statistics;2023-05-31

2. Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan;Frontiers in Medicine;2023-02-23

3. Descriptive Analysis for the Trend of Pharmacovigilance Planning in Risk Management Plans on New Drugs Approved During 2016–2019;Therapeutic Innovation & Regulatory Science;2022-08-13

4. Characterization of MID-NET<sup>®</sup> Data for Appropriate Drug Safety Assessment： Lessons Learned from Studies Investigating Incidence of Decreased Liver Function in Patients Prescribed Drugs for Pulmonary Arterial Hypertension and Examining Real World Utilization of Biosimilars;Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku;2022

5. Drug Safety Assessment and the MID-NET® (Japanese Medical Information Database Network);SpringerBriefs for Data Scientists and Innovators;2022